mangalore today
Sunday, March 07
Abish Buildersnamename


Rajasthan man dies 5 days after vaccination, panel says kidney issue led to haemorrhage

Mangalore Today News Network

Jaipur, Jan 22, 2021:    A panel probing adverse events following the vaccination against Covid-19 has investigated into the death of Suresh Chandra Sharma, who died five days after the vaccination in Rajasthan and concluded that the death was caused by his kidney ailment that led to brain haemorrhage.



The Adverse Event Following Immunization (AEFI) committee has investigated into the death of Suresh Chandra Sharma, an assistant administrative officer, who died in Chittorgarh district of Rajasthan.

In its report, the district AEFI committee has concluded that Sharma was suffering from high blood pressure and was a chronic patient of kidney disease which caused brain haemorrhage leading to his death and that his death has nothing to do with coronavirus vaccine dose he was administered.

Suresh Chandra Sharma passed away at Geetanjali Medical College in Udaipur district of Rajasthan on January 21. He was undergoing treatment for his chronic kidney ailment in Nadiad in Gujarat for the past three years.

A release signed by the Chief Medical and Health Officer of Chittorgarh concluded that the demise of Suresh Chandra Sharma happened due to serious brain haemorrhage caused by high blood pressure and a chronic kidney ailment and that it has nothing to do with Covid-19 vaccination.

So far, 44 cases of AEFI have been reported by the health department in Rajasthan since January 16, the day the first phase of coronavirus vaccination began in the state.

Till January 19, 32,379 people have been administered the coronavirus vaccine in Rajasthan. This is against a target of 49,131 people who were supposed to get the first shot of coronavirus vaccination in the state till January 19.

Courtesy:India Today

Write Comment | E-Mail To a Friend | Facebook | Twitter | Print
Write your Comments on this Article
Your Name
Native Place / Place of Residence
Your E-mail
Your Comment
You have characters left.
Security Validation
Enter the characters in the image above